Munehide Matsuhisa

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Involvement of Endoplasmic Reticulum Stress in Insulin Resistance and Diabetes

Yoshihisa Nakatani, Hideaki Kaneto, Dan Kawamori et al. · Journal of Biological Chemistry · 2004 · 464 citations · Full text

Life Sciences, Endocrinology, Physiology +14

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

Hideaki Kaneto, Yoshihisa Nakatani, Takeshi Miyatsuka et al. · Nature Medicine · 2004 · 336 citations

Medicine, Biotechnology, Endocrinology +12

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation

Dan Kawamori, Hideaki Kaneto, Yoshihisa Nakatani et al. · Journal of Biological Chemistry · 2005 · 255 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13